植物营养素对阿尔茨海默病的作用机制研究
Mechanism of Action of Phytonutrients on Alzheimer’s Disease
DOI: 10.12677/HJBM.2023.132012, PDF,    科研立项经费支持
作者: 丁洁莹*, 胡祥烽, 车土玲, 蓝 萍, 苏裕盛#:宁德师范学院医学院,福建 宁德
关键词: 阿尔茨海默病饮食儿茶素白藜芦醇姜黄素Alzheimer’s Disease Diet Catechin Resveratrol Curcumin
摘要: 阿尔茨海默病(Alzheimer’s Disease, AD)作为严重危害人类生命健康的疾病之一,面对日益加重的人口老龄化现象,全球罹患AD的患者只多不少。对于AD的研究人类仍处在预防和缓解的阶段,目前正在向着治疗AD的方向上发展钻研。饮食是人类日常生活中的一部分,可以作为预防和缓解AD病情的第一道保障,并非保健药物才可以发挥此类作用。一些有益物质可以从食物中获取,这些有益物质通过消除、抑制β淀粉样蛋白(Aβ protein, Aβ)的积累和tau的过度磷酸化,阻碍老年斑块的形成和进一步发展,增强线粒体的活性,激发相关酶的功能,来保护神经元及脑组织不受损伤,从这些方面上一定限度的对AD的病情起到了预防和缓解效果。但是由于AD的致病机制复杂,对其成因尚未有一个确切的定论。因此人们在饮食方面上对预防AD的进程愈发的重视起来,并取得了不少显著的成果,从中人们发现日常饮食在许多方面上对AD的进程有着抑制作用,进而降低罹患AD的风险。
Abstract: Dementia, also known as Alzheimer’s disease (AD), is one of the diseases that seriously endanger human life and health. Only a few patients suffer from AD worldwide in the face of the increasing aging of the population. The research on it is still in the stage of prevention and remission and research is developing towards the direction of treating AD. Diet as a part of human daily life is the first guarantee to prevent and relieve AD disease not only health care drugs can play such a role. Some beneficial substances can be obtained from food. These beneficial substances can prevent the formation and further development of aged plaques by eliminating and inhibiting the accumulation of Aβ protein (Aβ) and the over-phosphorylation of tau enhance the activity of mitochondria stimulate the function of related enzymes and protect neurons and brain tissue from damage. From these aspects to a certain extent, the disease of AD has played a preventive and alleviating effect. However, due to the complex pathogenesis of AD, there has not been an exact conclusion on its cause. Therefore, people pay more and more attention to preventing the process of AD in terms of diet and a lot of remarkable results have been achieved from which people find that daily diet has an inhibitory effect on the process of AD in many aspects, so as to reduce the risk of AD.
文章引用:丁洁莹, 胡祥烽, 车土玲, 蓝萍, 苏裕盛. 植物营养素对阿尔茨海默病的作用机制研究[J]. 生物医学, 2023, 13(2): 111-120. https://doi.org/10.12677/HJBM.2023.132012

参考文献

[1] Pritam, P., Deka, R., Bhardwaj, A., et al. (2022) Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology (Basel), 11, 212. [Google Scholar] [CrossRef] [PubMed]
[2] Matthews, K.A., Xu, W., Gaglioti, A.H., et al. (2019) Racial and Ethnic Estimates of Alzheimer’s Disease and Related Dementias in the United States (2015-2060) in Adults Aged >/=65 Years. Alzheimer’s & Dementia, 15, 17-24. [Google Scholar] [CrossRef] [PubMed]
[3] Stern, Y. (2012) Cognitive Reserve in Ageing and Alzheimer’s Disease. The Lancet Neurology, 11, 1006-1012. [Google Scholar] [CrossRef
[4] GBD (2019) Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 459-480. [Google Scholar] [CrossRef
[5] Hachinski, V., Einhaupl, K., Ganten, D., et al. (2019) Preventing Dementia by Preventing Stroke: The Berlin Manifesto. Alzheimer’s & Dementia, 15, 961-984. [Google Scholar] [CrossRef] [PubMed]
[6] Sanchez-Muniz, F.J., Macho-Gonzalez, A., Garcimartin, A., et al. (2019) The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease. Nutrients, 11, 1558. [Google Scholar] [CrossRef] [PubMed]
[7] 王星, 崔宇, 刘晶晶, 等. 阿尔茨海默病与日常膳食的关系[J]. 中国食品学报, 2021, 21(6): 375-379.
[8] 李嘉毓, 张媛媛, 郭琪, 等. 阿尔茨海默病的地中海饮食模式干预进展[J]. 现代临床护理, 2021, 20(7): 76-81.
[9] Cummings, J.L., Tong, G. and Ballard, C. (2019) Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options. Journal of Alzheimer’s Disease, 67, 779-794. [Google Scholar] [CrossRef
[10] Khan, S., Barve, K.H. and Kumar, M.S. (2020) Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease. Current Neuropharmacology, 18, 1106-1125. [Google Scholar] [CrossRef
[11] 李苏垚, 王玉银, 魏文悦, 等. 阿尔兹海默病的发病机制及其先天免疫性/适应性免疫研究. 山西大同大学学报(自然科学版), 2021, 37(6): 86-89.
[12] Kempuraj, D., Ahmed, M.E., Selvakumar, G.P., et al. (2020) Brain Injury-Mediated Neuroinflammatory Response and Alzheimer’s Disease. Neuroscientist, 26, 134-155. [Google Scholar] [CrossRef] [PubMed]
[13] Serrano-Pozo, A., Das, S. and Hyman, B.T. (2021) APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches. The Lancet Neurology, 20, 68-80. [Google Scholar] [CrossRef
[14] Babcock, K.R., Page, J.S., Fallon, J.R., et al. (2021) Adult Hippocampal Neurogenesis in Aging and Alzheimer’s Disease. Stem Cell Reports, 16, 681-693. [Google Scholar] [CrossRef] [PubMed]
[15] Bredesen, D.E., Amos, E.C., Canick, J., et al. (2016) Reversal of Cognitive Decline in Alzheimer’s Disease. Aging (Albany NY), 8, 1250-1258. [Google Scholar] [CrossRef] [PubMed]
[16] Agrawal, I. and Jha, S. (2020) Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia. Frontiers in Aging Neuroscience, 12, 252. [Google Scholar] [CrossRef] [PubMed]
[17] Pall, M.L. (2022) Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence. Current Alzheimer Research, 19, 119-132. [Google Scholar] [CrossRef] [PubMed]
[18] 王建华, 刘桂芳, 冯亚青, 等. Alzheimer病的Aβ假说及血管性假说研究进展[J]. 脑与神经疾病杂志, 2005(6): 477-479.
[19] Reeves, B.C., Karimy, J.K., Kundishora, A.J., et al. (2020) Glymphatic System Impairment in Alzheimer’s Disease and Idiopathic Normal Pressure Hydrocephalus. Trends in Molecular Medicine, 26, 285-295. [Google Scholar] [CrossRef] [PubMed]
[20] Nanclares, C., Baraibar, A.M., Araque, A., et al. (2021) Dysregulation of Astrocyte-Neuronal Communication in Alzheimer’s Disease. International Journal of Molecular Sciences, 22, 7887. [Google Scholar] [CrossRef] [PubMed]
[21] 张宁远, 郑锡军, 许羚, 等. 阿尔兹海默病的疾病进展模型与研究进展[J]. 中国临床药理学与治疗学, 2021, 26(6): 687-694.
[22] 王玉梅. 阿尔茨海默病发病机制Aβ假说的研究进展[J]. 中国临床研究, 2011, 24(11): 1042-1044.
[23] 马步勇. Aβ级联假说或tau蛋白假说, 哪个更正确?[J]. 上海交通大学学报, 2021, 55(S1): 58-59.
[24] Edwards, G.R., Zhao, J., Dash, P.K., et al. (2020) Traumatic Brain Injury Induces Tau Aggregation and Spreading. Journal of Neurotrauma, 37, 80-92. [Google Scholar] [CrossRef] [PubMed]
[25] Tang, S.J., Fesharaki-Zadeh, A., Takahashi, H., et al. (2020) Fyn Kinase Inhibition Reduces Protein Aggregation, Increases Synapse Density and Improves Memory in Transgenic and Traumatic Tauopathy. Acta Neuropathologica Communications, 8, 96. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, F., Zhong, R.J., Cheng, C., et al. (2021) New Therapeutics beyond Amyloid-Beta and Tau for the Treatment of Alzheimer’s Disease. Acta Pharmacologica Sinica, 42, 1382-1389. [Google Scholar] [CrossRef] [PubMed]
[27] Minter, M.R., Taylor, J.M. and Crack, P.J. (2016) The Contribution of Neuroinflammation to Amyloid Toxicity in Alzheimer’s Disease. Journal of Neurochemistry, 136, 457-474. [Google Scholar] [CrossRef] [PubMed]
[28] Sinsky, J., Pichlerova, K. and Hanes, J. (2021) Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies. International Journal of Molecular Sciences, 22, 9207. [Google Scholar] [CrossRef] [PubMed]
[29] 苏霄, 赵世刚, 赵婷婷, 等. 阿尔兹海默病发病机制的新进展[J]. 中华临床医师杂志(电子版), 2021, 15(3): 224-228.
[30] Pervin, M., Unno, K., Takagaki, A., et al. (2019) Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and Its Metabolites. International Journal of Molecular Sciences, 20, 3630. [Google Scholar] [CrossRef] [PubMed]
[31] Sweeney, M.D., Sagare, A.P. and Zlokovic, B.V. (2018) Blood-Brain Barrier Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders. Nature Reviews Neurology, 14, 133-150. [Google Scholar] [CrossRef] [PubMed]
[32] Yin, F., Sancheti, H., Patil, I., et al. (2016) Energy Metabolism and Inflammation in Brain Aging and Alzheimer’s Disease. Free Radical Biology and Medicine, 100, 108-122. [Google Scholar] [CrossRef] [PubMed]
[33] Liccardo, D., Marzano, F., Carraturo, F., et al. (2020) Potential Bidirectional Relationship between Periodontitis and Alzheimer’s Disease. Frontiers in Physiology, 11, 683. [Google Scholar] [CrossRef] [PubMed]
[34] Nunomura, A. and Perry, G. (2020) RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 2638130. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, X., Wang, W., Li, L., et al. (2014) Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease. Biochimica et Biophysica Acta, 1842, 1240-1247. [Google Scholar] [CrossRef] [PubMed]
[36] Rahman, M.A., Hannan, M.A., Uddin, M.J., et al. (2021) Exposure to Environmental Arsenic and Emerging Risk of Alzheimer’s Disease: Perspective Mechanisms, Management Strategy, and Future Directions. Toxics, 9, 188. [Google Scholar] [CrossRef] [PubMed]
[37] Kamat, P.K., Kalani, A., Rai, S., et al. (2016) Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies. Molecular Neurobiology, 53, 648-661. [Google Scholar] [CrossRef] [PubMed]
[38] Tonnies, E. and Trushina, E. (2017) Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 57, 1105-1121. [Google Scholar] [CrossRef
[39] Awasthi, S., Hindle, A., Sawant, N.A., et al. (2021) RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease. Cells, 10, 3113. [Google Scholar] [CrossRef] [PubMed]
[40] Pluta, R., Ulamek-Koziol, M., Januszewski, S., et al. (2020) Gut Microbiota and Pro/Prebiotics in Alzheimer’s Disease. Aging (Albany NY), 12, 5539-5550. [Google Scholar] [CrossRef] [PubMed]
[41] Lotti-Mesa, R.L. and Gutierrez-Gacel, L. (2019) The Microbiota-Gut-Brain Axis, Future Therapeutic Target in Neurodegenerative Diseases. Revue Neurologique, 69, 43-44. [Google Scholar] [CrossRef] [PubMed]
[42] Leclerc, M., Dudonne, S. and Calon, F. (2021) Can Natural Products Exert Neuroprotection without Crossing the Blood-Brain Barrier? International Journal of Molecular Sciences, 22, 3356. [Google Scholar] [CrossRef] [PubMed]
[43] Ghaisas, S., Maher, J. and Kanthasamy, A. (2016) Gut Microbiome in Health and Disease: Linking the Microbiome-Gut-Brain Axis and Environmental Factors in the Pathogenesis of Systemic and Neurodegenerative Diseases. Pharmacology & Therapeutics, 158, 52-62. [Google Scholar] [CrossRef] [PubMed]
[44] Sochocka, M., Donskow-Lysoniewska, K., Diniz, B.S., et al. (2019) The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—A Critical Review. Molecular Neurobiology, 56, 1841-1851. [Google Scholar] [CrossRef] [PubMed]
[45] Shabbir, U., Arshad, M.S., Sameen, A., et al. (2021) Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients, 13, 690. [Google Scholar] [CrossRef] [PubMed]
[46] Akter, R., Afrose, A., Rahman, M.R., et al. (2021) A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer’s Disease, Aging, Cancer, Inflammation, and Diabetes. International Journal of Molecular Sciences, 22, 4180. [Google Scholar] [CrossRef] [PubMed]
[47] Gruendler, R., Hippe, B., Sendula, J.V., et al. (2020) Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer’s Disease: A Systematic Review. Molecules, 25, 6018. [Google Scholar] [CrossRef] [PubMed]
[48] Davinelli, S., Sapere, N., Zella, D., et al. (2012) Pleiotropic Protective Effects of Phytochemicals in Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity, 2012, Article ID: 386527. [Google Scholar] [CrossRef] [PubMed]
[49] 刘彦霞, 黄汉昌, 常平, 等. 儿茶素类物质在阿尔茨海默病中的神经保护作用机制[J]. 天然产物研究与开发, 2013, 25(11): 1607-1613.
[50] Musial, C., Kuban-Jankowska, A. and Gorska-Ponikowska, M. (2020) Beneficial Properties of Green Tea Catechins. International Journal of Molecular Sciences, 21, 1744. [Google Scholar] [CrossRef] [PubMed]
[51] Pervin, M., Unno, K., Ohishi, T., et al. (2018) Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules, 23, 1297. [Google Scholar] [CrossRef] [PubMed]
[52] Prasanth, M.I., Sivamaruthi, B.S., Chaiyasut, C., et al. (2019) A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy. Nutrients, 11, 474. [Google Scholar] [CrossRef] [PubMed]
[53] Acharya, A., Stockmann, J., Beyer, L., et al. (2020) The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-beta Secondary Structure. Biophysical Journal, 119, 349-359. [Google Scholar] [CrossRef] [PubMed]
[54] Jiang, L., Zhao, J., Cheng, J.X., et al. (2020) Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association with RNA Binding Proteins. Frontiers in Neurology, 11, Article ID: 579434. [Google Scholar] [CrossRef] [PubMed]
[55] Wobst, H.J., Sharma, A., Diamond, M.I., et al. (2015) The Green Tea Polyphenol (-)-epigallocatechin Gallate Prevents the Aggregation of Tau Protein into Toxic Oligomers at Substoichiometric Ratios. FEBS Letters, 589, 77-83. [Google Scholar] [CrossRef] [PubMed]
[56] Okello, E.J. and Mather, J. (2020) Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer’s Disease. Nutrients, 12, 1090. [Google Scholar] [CrossRef] [PubMed]
[57] Hussain, T., Tan, B., Yin, Y., et al. (2016) Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxidative Medicine and Cellular Longevity, 2016, Article ID: 7432797. [Google Scholar] [CrossRef] [PubMed]
[58] Forman, H.J. and Zhang, H. (2021) Targeting Oxidative Stress in Disease: Promise and Limitations of Antioxidant Therapy. Nature Reviews Drug Discovery, 20, 689-709. [Google Scholar] [CrossRef] [PubMed]
[59] Adami, G.R., Tangney, C. and Schwartz, J.L., et al. (2020) Gut/Oral Bacteria Variability May Explain the High Efficacy of Green Tea in Rodent Tumor Inhibition and Its Absence in Humans. Molecules, 25, 4753. [Google Scholar] [CrossRef] [PubMed]
[60] Poljsak, B., Suput, D. and Milisav, I. (2013) Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants. Oxidative Medicine and Cellular Longevity, 2013, Article ID: 956792. [Google Scholar] [CrossRef] [PubMed]
[61] Malaguarnera, L. (2019) Influence of Resveratrol on the Immune Response. Nutrients, 11, 946. [Google Scholar] [CrossRef] [PubMed]
[62] Gomes, B., Silva, J., Romeiro, C., et al. (2018) Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 8152373. [Google Scholar] [CrossRef] [PubMed]
[63] 左灵燕, 朱冯婷, 帅红艳, 等. 白藜芦醇及其代谢产物治疗阿尔茨海默病的研究进展[J]. 国际神经病学神经外科学杂志, 2021, 48(4): 382-386.
[64] Jia, Y., Wang, N. and Liu, X. (2017) Resveratrol and Amyloid-Beta: Mechanistic Insights. Nutrients, 9, 1122. [Google Scholar] [CrossRef] [PubMed]
[65] Meng, T., Xiao, D., Muhammed, A., et al. (2021) Anti-Inflammatory Action and Mechanisms of Resveratrol. Molecules, 26, 229. [Google Scholar] [CrossRef] [PubMed]
[66] Li, Y., Zhang, J., Wan, J., et al. (2020) Melatonin Regulates Abeta Production/Clearance Balance and Abeta Neurotoxicity: A Potential Therapeutic Molecule for Alzheimer’s Disease. Biomedicine & Pharmacotherapy, 132, Article ID: 110887. [Google Scholar] [CrossRef] [PubMed]
[67] Lyu, Z., Chan, Y., Li, Q., et al. (2021) Destructive Effects of Pyroptosis on Homeostasis of Neuron Survival Associated with the Dysfunctional BBB-Glymphatic System and Amyloid-Beta Accumulation after Cerebral Ischemia/Reperfusion in Rats. Neural Plasticity, 2021, Article ID: 4504363. [Google Scholar] [CrossRef] [PubMed]
[68] Yang, A., Bagit, A. and Macpherson, R. (2021) Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease. International Journal of Molecular Sciences, 22, 4628. [Google Scholar] [CrossRef] [PubMed]
[69] Ai, Z., Li, C., Li, L., et al. (2015) Resveratrol Inhibits Beta-Amyloid-Induced Neuronal Apoptosis via Regulation of p53 Acetylation in PC12 Cells. Molecular Medicine Reports, 11, 2429-2434. [Google Scholar] [CrossRef] [PubMed]
[70] 李娟, 聂晶, 张敏. 姜黄素对阿尔茨海默病(AD)模型大鼠的抗痴呆作用研究[J]. 医学研究杂志, 2013, 42(6): 173-176.
[71] Chainoglou, E. and Hadjipavlou-Litina, D. (2020) Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids. International Journal of Molecular Sciences, 21, 1975. [Google Scholar] [CrossRef] [PubMed]
[72] 郗红娟. 姜黄素在阿尔茨海默病中相关作用机制的研究[J]. 生物技术世界, 2015(9): 83.
[73] 杨融辉, 张宁. 姜黄素对阿尔茨海默病作用机制的研究进展[J]. 东南大学学报(医学版), 2015, 34(1): 152-155.
[74] 张莉莉, 査晓明, 楼影涵, 等. 姜黄素对阿尔茨海默病中Aβ诱导的神经毒性保护作用的研究进展[J]. 亚太传统医药, 2012, 8(8): 199-201.
[75] Goozee, K.G., Shah, T.M., Sohrabi, H.R., et al. (2016) Examining the Potential Clinical Value of Curcumin in the Prevention and Diagnosis of Alzheimer’s Disease. British Journal of Nutrition, 115, 449-465. [Google Scholar] [CrossRef
[76] 陈娟丽, 魏传飞, 韩发彬. 姜黄素改善阿尔茨海默病认知和记忆功能的研究进展[J]. 中国老年学杂志, 2021, 41(4): 887-891.
[77] 林文娟, 尹大川. 姜黄素抑制TAU蛋白聚集治疗阿尔茨海默症的研究进展[J]. 当代医学, 2021, 27(9): 190-194.
[78] Pluta, R., Ulamek-Koziol, M. and Czuczwar, S.J. (2018) Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer’s Disease Phenotype. International Journal of Molecular Sciences, 19, 4002. [Google Scholar] [CrossRef] [PubMed]